NMRA
Neumora Therapeutics, Inc. · Healthcare
Head of R, D Robert A. Lenz sold $377K of Neumora Therapeutics, Inc.
Sold$376,665
$11.43Price
32,948Shares
−8%Stake
What NMRA did after the filing
- The stock from Mon, Sep 16 close, $11.94
- −0.8%
- S&P 500, same days
- +3.5%
Measured over 30 trading days, to the Oct 28 close.
Traded Thu, Sep 12. Filed Mon, Sep 16, 12:05 PM ET, during the session. Returns use the Sep 16 close and the Oct 28 close. Not investment advice.